XtalPi Inc., a Sino-U.S. artificial intelligence firm, has signed a memorandum of understanding (MOU) with the Advanced Biomedical Instrumentation Centre (ABIC) at the University of Hong Kong (UHK) to foster collaboration aimed at enhancing research and commercial applications of ABIC’s technological advancements both locally and internationally.
Under the terms of the agreement, XtalPi will assess the commercialization potential of ABIC’s technology assets and intellectual property portfolio. The company will also spearhead the commercial implementation of select ABIC technologies and share its expertise in product development and research translation. Financial details of the collaboration were not disclosed.
XtalPi leverages quantum physics, artificial intelligence, and automated robotics to innovate in drug discovery and material development. ABIC, on the other hand, comprises a team of interdisciplinary experts from UHK and researchers from Harvard University’s School of Engineering and Applied Sciences.- Flcube.com
